GlassScriptPhysician profile
Vincent Rebugio
NPI 1194250928
$286.33
in general payments reported to CMS, 2019-2025
9 companies · $114 in 2025
The $114 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $70.58 · 2023: $36.33 · 2024: $65.46 · 2025: $114.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $216.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $215.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $117.38 | 2022-2025 | |
| Melinta Therapeutics, LLC | $49.13 | 2023-2025 | Rezzayo, Kimyrsa |
| Hartmann USA, INC. | $29.24 | 2025 | Zetuvit Plus 10x10 P10 |
| Advanced Oxygen Therapy INC. | $24.71 | 2024 | Topical Oxygen Chamber For Extremities |
| Exact Sciences Corporation | $21.56 | 2025 | Cologuard Collection Kit |
| Organogenesis INC. | $14.33 | 2024 | Puraply Am |
| Paratek Pharmaceuticals, INC. | $12.79 | 2023 | Nuzyra |
| Evofem Biosciences, INC. | $11.64 | 2025 | Solosec, Phexx, Phexxi |
| Organon LLC | $5.55 | 2025 | Nexplanon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vincent Rebugio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.